Core Insights - The article highlights the approval of seven innovative medical devices by the NMPA, indicating a significant advancement in the domestic medical device industry in China [1]. Group 1: Innovative Medical Devices - The self-expanding intracranial drug-eluting stent system developed by Lilan Biotechnology (Suzhou) Co., Ltd. focuses on providing minimally invasive and safe treatment solutions for cerebrovascular diseases, leveraging advanced biomaterials technology [2]. - The implantable wireless brain-machine interface system from Shanghai Ladder Medical Technology Co., Ltd. is designed for applications in motor control, neurological disease monitoring, and sensory restoration, marking a significant innovation in the field [3][4]. - The X-ray computed tomography equipment from Siemens Medical Solutions (Shanghai) Co., Ltd. serves as a major global R&D and manufacturing center for medical imaging devices, contributing to precision medicine and digital diagnosis [5][6]. - The cartilage regeneration scaffold developed by Zhejiang Xingyue Biotechnology Co., Ltd. aims to repair large cartilage defects and represents a major innovation in regenerative medicine, filling a gap in domestic products [6]. - The collagen meniscus implant from Beijing Bansai Technology Co., Ltd. focuses on repairing meniscus injuries and aims to address knee instability issues post-meniscectomy, promoting clinical application of 3D printing technology in orthopedics [7]. - The thyroglobulin (Tg) gene mRNA detection kit developed by Shanghai Ruijing Biotechnology Co., Ltd. provides comprehensive solutions for thyroid cancer diagnosis and monitoring, serving numerous hospitals across multiple provinces [8]. - Guangzhou Weishi Bosheng Biotechnology Co., Ltd. specializes in minimally invasive ophthalmic devices, focusing on innovative products for glaucoma and retinal detachment treatment, emphasizing micro-invasiveness and biocompatibility [8].